Opulen Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$311K Buy
259
+36
+16% +$36.8K 0.2% 87
2026
Q1
$205K Buy
223
+14
+7% +$14.2K 0.14% 114
2025
Q4
$225K Buy
+209
New +$200K 0.16% 98

Other funds holding LLY

Opulen Financial Group's LLY Position: Q2 2026 in Review

Opulen Financial Group increased its Eli Lilly (LLY) stake by 16% in Q2 2026, buying an estimated $36.8K and bringing the position to 259 shares worth $311K. The position accounts for 0.2% of the portfolio, ranked #87.

Opulen Financial Group first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Opulen Financial Group held 259 shares of Eli Lilly worth $311K as of Q2 2026.
  • Opulen Financial Group bought 36 Eli Lilly shares in Q2 2026, an estimated $36.8K.
  • Eli Lilly made up 0.2% of Opulen Financial Group's portfolio in Q2 2026, its #87 holding.
  • Opulen Financial Group first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Opulen Financial Group's 13F filing for Q2 2026, filed 27 Jul 2026.